Novartis AG Stock News

The latest trading day saw Novartis (NVS) settling at $107.45, representing a -0.14% change from its previous close.

Cytokinetics stock plunged more than 16% Thursday to $84.95 after talks reportedly broke down with potential potential buyer Novartis AG (ADR) (NYSE:NVS).  Shares of the biopharmaceutical company hav

Novartis has backed away from its pursuit of Cytokinetics.

Will stocks continue into 2024? Stock Strategist Andrew Rocco shares his prediction and unveils 3 important market areas to monitor.

iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must Watch

Novartis AG (NVS) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)

Novartis CEO Vasant Narasimhan joins 'Money Movers' to discuss the company's overall M&A strategy, the businesses that Narasimhan wanted to get out of, and how big the Entresto drug can be.

Cytokinetics Inc (NASDAQ: CYTK) popped another 15% on Monday following a report that Novartis AG (SWX: NOVN) is now in advanced talks to acquire the biopharmaceutical firm.

Novartis NOVN, +0.43% is close to acquiring Cytokinetics Inc. CYTK, +15.04% and its promising heart drug, according to a Wall Street Journal report Monday. A deal for South San Francisco-based Cytokin

Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug.

Voyager Therapeutics Inc. NASDAQ: VYGR is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took a 30% spike on news of its partnership with Novart

Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic differences.

Alphabet unit Isomorphic Labs, which uses AI to help discover new drugs, entered collaboration deals with Eli Lilly and Novartis.

Isomorphic Labs, the London-based, drug discovery-focused spin-out of Google AI R&D division DeepMind, today announced that it's entered into strategic partnerships with two pharmaceutical giants, Eli

The Pharmaceutical segment offers human health pharmaceutical products in: Oncology, Hospital acute care Immunology Neuroscience Virology Cardiovascular and diabetes Vaccine products, such as preventi